Back to today’s briefing

Story perspectives

Trump Unveils Medicare Drug Price Cuts, Savings Ahead

11/29/2025

42 4 Full Breakdown

Summary

Story summary

U.S. President Donald Trump announced that Medicare will lower prices for 15 prescription drugs, including Ozempic and Wegovy, with discounts from 38% to 85% and effective in 2027.
The plan is part of the Inflation Reduction Act of 2022, projecting $12 billion in Medicare savings and $685 million in reduced out-of-pocket costs.
A second round of negotiations is planned for early 2026 amid industry resistance.

History

Historical Context

The Inflation Reduction Act of 2022, signed by President Biden on August 16, aims to lower prescription drug costs and enhance Medicare's negotiating power, a shift from the 2003 Medicare Modernization Act that restricted such negotiations. The act anticipates $12 billion in savings from price reductions on 15 drugs, reflecting ongoing tensions between the government and pharmaceutical companies over high drug prices.

1 of 2

Story summary

U.S. President Donald Trump announced that Medicare will lower prices for 15 prescription drugs, including Ozempic and Wegovy, with discounts from 38% to 85% and effective in 2027.
The plan is part of the Inflation Reduction Act of 2022, projecting $12 billion in Medicare savings and $685 million in reduced out-of-pocket costs.
A second round of negotiations is planned for early 2026 amid industry resistance.

1 / 2